Characterization of the Clinical Features in HBV-Related Acute-on-Chronic Liver Failure

被引:0
|
作者
Yuan, Hong-Xiang [1 ]
Su, Jian-Rong [2 ]
Zhang, Qiu-Yun [3 ]
Zhao, Yan [1 ]
Yu, Yan-Hua [1 ]
Lou, Jin-Li [1 ]
机构
[1] Capital Med Univ, Beijing Youan Hosp, Clin Lab Ctr, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Friendship Hosp, Clin Lab Ctr, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Key Lab Tradit Chinese Med, Collateral Dis Res, Tradit Chinese Med Acad, Beijing, Peoples R China
基金
北京市自然科学基金;
关键词
BACTERIAL-INFECTIONS; ACUTE DECOMPENSATION; CIRRHOSIS; PATHOGENESIS; MORTALITY;
D O I
暂无
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective . Acute-on-chronic liver failure (ACLF) is a type of liver failure commonly found in China, and currently the mechanism of the disease remains unknown. This study aimed to investigate the epidemiology, clinical features and prognostic factors in ACLF. Methods . This study retrospectively included 170 patients with ACLF admitted to Beijing Friendship Hospital in Beijing, China from November 2017 to May 2019. Patients were divided into 2 groups: the improved group and the deteriorated group, according to the severity of their disease. Patients' demographic data; clinical manifestations; complications; laboratory indicators including platelets (PLT), alanine aminotransferase (ALT), aspartate amino transferase (AST), total bilirubin (TBIL), prothrombin time (PT), activated partial thromboplastin time (APTT), prothrombin activity (PTA), international normalized ratio (INR), and alkaline phosphatase (ALP) were collected. The relationship between these factors and the patients' prognosis were analyzed by logistic multivariate regression analysis. Results . The highest morbidity rate was in the age group 40 to 49 years (29.41%). The age group with the second highest morbidity was between 50 and 59 years (25.29%), followed by >60 (21.18%), 30 to 39 (20.59%), 20 to 29 (2.94%) and <20 years (0.59%). A total of 53 patients (31.18%) had a family history of hepatitis B virus infection. The patients' main clinical manifestations were ascites (77.65%) and weakness (68.23%). The most common complications were hypoalbuminemia (80%), infection (67.65%) and electrolyte imbalance (44.12%). In addition, the PTA (P = .009), hepatorenal syndrome (P = .005) and hepatic encephalopathy (level IV) (P = .005) were independently related to the prognosis of ACLF. There is a significant relationship between complications and prognosis (chi(2) = 8.502; P = .004). Conclusion . This study showed that prothrombin activity, hepatorenal syndrome and hepatic encephalopathy were independently related to the prognosis of ACLF. This outcome provided more options for reducing patient mortality in clinic.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 50 条
  • [21] A new multiparameter integrated MELD model for prognosis of HBV-related acute-on-chronic liver failure
    Luo, Yue
    Xu, Yun
    Li, Mingming
    Xie, Ya
    Gong, Guozhong
    MEDICINE, 2016, 95 (34)
  • [22] Validation of non-invasive tools in predicting HBV-related acute-on-chronic liver failure
    Wu, Ting
    Chen, Tao
    Ning, Qin
    HEPATOLOGY INTERNATIONAL, 2021, 15 (03) : 571 - 574
  • [23] Prognostic value of plasma level of superoxide dismutase in HBV-related acute-on-chronic liver failure
    Yao, Naijuan
    He, Yajuan
    Wu, Yuchao
    Wang, Fei
    Tian, Zhen
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [24] STING modulates HBV-related acute-on-chronic liver failure by mediating autophagy and macrophage polarization
    Zhang, Hao
    Liang, Teng
    Duan, Wanlu
    Liu, Futing
    Li, Liping
    Liu, Qian
    Li, Jianfei
    Zong, Qiyin
    Jin, Lei
    Wang, Qin
    Zhou, Qiang
    IMMUNOBIOLOGY, 2025, 230 (01)
  • [25] Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure
    Shi, X.
    Zhu, P.
    Yan, G.
    Liu, C.
    Zhang, C.
    Huang, G.
    Zhang, Y.
    Yan, Z.
    Wang, Y.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (11) : 920 - 929
  • [26] The clinical courses of HBV-related acute-on-chronic liver failure and a multi-state model to predict disease evolution
    Yu, Xia
    Liu, Xinxin
    Tan, Wenting
    Wang, Xiaobo
    Zheng, Xin
    Huang, Yan
    Chen, Jinjun
    Li, Beiling
    Meng, Zhongji
    Gao, Yanhang
    Qian, Zhiping
    Liu, Feng
    Lu, Xiaobo
    Shang, Jia
    Yan, Huadong
    Zheng, Yubao
    Zhang, Weituo
    Yin, Shan
    Gu, Wenyi
    Deng, Guohong
    Xiang, Xiaomei
    Zhou, Yi
    Hou, Yixin
    Zhang, Qun
    Xiong, Shue
    Liu, Jing
    Chen, Ruochan
    Long, Liyuan
    Jiang, Xiuhua
    Luo, Sen
    Chen, Yuanyuan
    Jiang, Chang
    Zhao, Jinming
    Ji, Liujuan
    Mei, Xue
    Li, Jing
    Li, Tao
    Zheng, Rongjiong
    Zhou, Xinyi
    Ren, Haotang
    Sheng, Jifang
    Li, Hai
    Shi, Yu
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (01)
  • [27] A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure
    Li, Peng
    Liang, Xi
    Xu, Shan
    Xiong, Ye
    Huang, Jianrong
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [28] A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure
    Peng Li
    Xi Liang
    Shan Xu
    Ye Xiong
    Jianrong Huang
    Scientific Reports, 11
  • [29] Predicting the survival benefit of liver transplantation in HBV-related acute-on-chronic liver failure: an observational cohort study
    Li, Peng
    Liang, Xi
    Luo, Jinjin
    Li, Jiaqi
    Xin, Jiaojiao
    Jiang, Jing
    Shi, Dongyan
    Lu, Yingyan
    Hassan, Hozeifa Mohamed
    Zhou, Qian
    Hao, Shaorui
    Zhang, Huafen
    Wu, Tianzhou
    Li, Tan
    Yao, Heng
    Ren, Keke
    Guo, Beibei
    Zhou, Xingping
    Chen, Jiaxian
    He, Lulu
    Yang, Hui
    Hu, Wen
    Ma, Shiwen
    Li, Bingqi
    You, Shaoli
    Xin, Shaojie
    Chen, Yu
    Li, Jun
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2023, 32
  • [30] Characteristics of circulating immune cells in HBV-related acute-on-chronic liver failure following artificial liver treatment
    Tao Ju
    Daixi Jiang
    Chengli Zhong
    Huafen Zhang
    Yandi Huang
    Chunxia Zhu
    Shigui Yang
    Dong Yan
    BMC Immunology, 24